MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$214,158K
(19.41%↑ Y/Y)
Cash and cash
equivalents
$62,431K
(-40.63%↓ Y/Y)
Tax incentive
receivable
$56,431K
(13.75%↑ Y/Y)
Prepaid expenses and
other current assets
$15,659K
(15.10%↑ Y/Y)
Total current assets
$348,679K
(0.28%↑ Y/Y)
Long-term investments
$257,117K
(83.14%↑ Y/Y)
Deferred tax asset
$24,171K
(-8.41%↓ Y/Y)
Operating lease
right-of-use assets
$9,794K
(-9.13%↓ Y/Y)
Other non-current
assets
$1,280K
(-31.99%↓ Y/Y)
Property and equipment,
net
$722K
(6.02%↑ Y/Y)
Total assets
$641,763K
(21.58%↑ Y/Y)
Total liabilities and
shareholders' equity
$641,763K
(21.58%↑ Y/Y)
Total shareholders
equity
$487,348K
(26.18%↑ Y/Y)
Total liabilities
$154,415K
(9.05%↑ Y/Y)
Accumulated deficit
-$1,265,475K
(-24.70%↓ Y/Y)
Additional paid-in capital
$1,750,996K
(25.19%↑ Y/Y)
Long term debt
$110,440K
(1.09%↑ Y/Y)
Total current
liabilities
$36,574K
(51.12%↑ Y/Y)
Operating lease
liabilities
$7,372K
(-9.16%↓ Y/Y)
Other liabilities
$29K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income
$1,408K
(-32.14%↓ Y/Y)
Ordinary shares 0.002
nominal...
$419K
(15.75%↑ Y/Y)
Accrued expenses and
other current...
$25,916K
(35.90%↑ Y/Y)
Accounts payable
$10,658K
(107.68%↑ Y/Y)
Back
Back
Balance Sheet
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)
source: myfinsight.com